ConvaTec Group Plc operates as holding company, which engages in medical business. The firm is engaged in the development, manufacture and sale of medical products, services, and technologies. The company is focused on solutions for the management of chronic conditions. The company markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Advanced Wound Care includes advanced dressings for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories, and personalized services for individuals with a stoma. Continence and Critical Care includes products and services for people with urinary continence issues related to spinal cord injuries and other causes. Infusion Care includes disposable infusion sets used in insulin pump therapy for people with diabetes.
Follow-Up Questions
Who is the CEO of ConvaTec Group PLC?
Mr. Karim Bitar is the Chief Executive Officer of ConvaTec Group PLC, joining the firm since 2019.
What is the price performance of CNVVF stock?
The current price of CNVVF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for ConvaTec Group PLC?
ConvaTec Group PLC belongs to Health Care industry and the sector is Health Care
What is ConvaTec Group PLC market cap?
ConvaTec Group PLC's current market cap is $0
Is ConvaTec Group PLC a buy, sell, or hold?
According to wall street analysts, 22 analysts have made analyst ratings for ConvaTec Group PLC, including 5 strong buy, 14 buy, 3 hold, 0 sell, and 5 strong sell
